Xie Xinglei, Liu Jiaming, García-Patterson Apolonia, Chico Ana, Mateu-Salat Manel, Amigó Judit, Adelantado Juan María, Corcoy Rosa
Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain.
Institut d'Investigació Biomèdica Sant Pau (IIB Sant Pau), Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Acta Diabetol. 2023 May;60(5):621-629. doi: 10.1007/s00592-023-02031-0. Epub 2023 Jan 27.
We aimed to explore the relationship between gestational weight gain (GWG) after Institute of Medicine (IOM) and pregnancy outcomes in women with type 1 and type 2 diabetes.
Retrospective cohort study at a tertiary medical center (1981-2011).
2 maternal and 14 fetal. Main exposure variable: GWG according to IOM. We calculated crude and adjusted ORs as well as population attributable (PAF) and preventable fractions (PPF) for significant positive and negative associations, respectively.
We evaluated 633 pregnant women with type 1 or type 2 diabetes. GWG was insufficient (iGWG) in 16.7% and excessive (eGWG) in 50.7%. In the adjusted analysis, GWG according to IOM was significantly associated with maternal outcomes (pregnancy-induced hypertension and cesarean delivery) and four fetal outcomes (large-for-gestational age, macrosomia, small-for-gestational age and neonatal respiratory distress). The association with large-for-gestational age newborns was negative for iGWG (0.48, CI 95% 0.25-0.94) and positive for eGWG (1.76, CI 95% 1.18-2.63). In addition, iGWG was associated with a higher risk of small-for-gestational age newborns and respiratory distress and eGWG with a higher risk of pregnancy-induced hypertension, caesarean delivery and macrosomia. PAF and PPF ranged from the 20.4% PPF of iGWG for large-for-gestational age to 56.5% PAF of eGWG for macrosomia.
In this cohort of women with type 1 or type 2 diabetes, inadequate GWG after IOM was associated with adverse pregnancy outcomes; associations were unfavorable for eGWG and mixed for iGWG. The attributable fractions were not moderate, pointing to the potential impact of modifying inadequate GWG.
我们旨在探讨美国医学研究所(IOM)发布的孕期体重增加(GWG)标准与1型和2型糖尿病女性妊娠结局之间的关系。
在一家三级医疗中心进行回顾性队列研究(1981 - 2011年)。
2项母亲相关变量和14项胎儿相关变量。主要暴露变量:根据IOM标准的GWG。我们分别计算了显著正相关和负相关的粗比值比和调整后比值比,以及人群归因分数(PAF)和可预防分数(PPF)。
我们评估了633例1型或2型糖尿病孕妇。其中16.7%的孕妇GWG不足(iGWG),50.7%的孕妇GWG过度(eGWG)。在调整分析中,根据IOM标准的GWG与母亲结局(妊娠期高血压和剖宫产)以及四项胎儿结局(大于胎龄儿、巨大儿、小于胎龄儿和新生儿呼吸窘迫)显著相关。iGWG与大于胎龄儿新生儿的关联为负(0.48,95%可信区间0.25 - 0.94),eGWG与大于胎龄儿新生儿的关联为正(1.76,95%可信区间1.18 - 2.63)。此外,iGWG与小于胎龄儿新生儿和呼吸窘迫的风险较高相关,eGWG与妊娠期高血压、剖宫产和巨大儿的风险较高相关。PAF和PPF范围从iGWG对大于胎龄儿的20.4% PPF到eGWG对巨大儿的56.5% PAF。
在这组1型或2型糖尿病女性中,IOM标准后GWG不足与不良妊娠结局相关;eGWG的关联不利,iGWG的关联则好坏参半。归因分数不中等,表明改善不足的GWG具有潜在影响。